J. Wollenhaupt
Helmholtz-Zentrum Berlin für Materialien und Energie · 374 works · 899 citations · h-index 14
Top works
- X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
- F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening
- The large N-terminal region of the Brr2 RNA helicase guides productive spliceosome activation
- A composite double-/single-stranded RNA-binding region in protein Prp3 supports tri-snRNP stability and splicing
- Redox-Sensing Under Hypochlorite Stress and Infection Conditions by the Rrf2-Family Repressor HypR in Staphylococcus aureus
- Synthesis of 2′-Fluoro RNA by Syn5 RNA polymerase
- Binding Adaptation of GS-441524 Diversifies Macro Domains and Downregulates SARS-CoV-2 de-MARylation Capacity
- FragMAXapp: crystallographic fragment-screening data-analysis and project-management system
- Frag4Lead: growing crystallographic fragment hits by catalog using fragment-guided template docking
- Facilitated crystal handling using a simple device for evaporation reduction in microtiter plates
- Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin
- Interplay ofcis- andtrans-regulatory mechanisms in the spliceosomal RNA helicase Brr2
- Where and how to house big data on small fragments
- Of problems and opportunities—How to treat and how to not treat crystallographic fragment screening data
- Large-Scale Crystallographic Fragment Screening Expedites Compound Optimization and Identifies Putative Protein–Protein Interaction Sites
- Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin
- Intrinsically Disordered Protein Ntr2 Modulates the Spliceosomal RNA Helicase Brr2
- The MECP2‐TRD domain interacts with the DNMT3A‐ADD domain at the H3 ‐tail binding site
- Large-scale ratcheting in a bacterial DEAH/RHA-type RNA helicase that modulates antibiotics susceptibility
- Fragment‐Based Design, Synthesis, and Characterization of Aminoisoindole‐Derived Furin Inhibitors